Evidence That Changes Practice. Not Just the Literature.
Clinical data is the most strategically valuable asset a healthcare organization holds. But data without a strategy is just a file.
We help you decide what evidence to generate, how to generate it purposefully, and how to communicate it so that it reaches the people whose decisions it is meant to inform.
Evidence Strategy
Clinical data is the most strategically valuable asset a healthcare organization holds. But data without a strategy is just a file. Gabriel & Co helps organizations determine what evidence to generate, how to generate it purposefully, and how to communicate it in a way that changes clinical practice, not just the literature.
Evidence Gap Assessment
Map the current evidence landscape, what exists, what is missing, what clinical and payer audiences need to see, and what those gaps are costing you.
Deliverables:
Evidence Gap Report with prioritized recommendations and quick-win opportunities.
Ideal for:
- Products underperforming relative to clinical potential.
- Early-stage companies building evidence architecture.
Evidence Generation Roadmap
A multi-year strategic blueprint for all evidence activity; RWE, post-marketing studies, investigator-initiated research, registry participation, and health economics.
Deliverables:
Prioritized Evidence Generation Plan with study designs, timelines, and endpoints.
Ideal for:
- Companies needing a systematic, fit-for-purpose evidence plan, not a reactive publication list.
Publication & Scientific Communication Strategy
A complete strategy for how your evidence reaches its intended audiences – peer-reviewed publications, congress presentations, medical education, and HCP-facing communication.
Deliverables:
Publication Plan and Scientific Communication Framework aligned to product strategy.
Ideal for:
- Organizations generating evidence but communicating it reactively.